Cullinan Therapeutics (CGEM) Other Accumulated Expenses (2021 - 2025)

Cullinan Therapeutics' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $996000.0 for Q4 2025.

• In Q4 2025, Other Accumulated Expenses fell 30.69% year-over-year to $996000.0; the TTM figure through Dec 2025 stood at $996000.0 (down 30.69% YoY), while the FY2025 annual figure was $996000.0, down 30.69% from the prior year.
• Other Accumulated Expenses for Q4 2025 stood at $996000.0, down from $1.4 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $2.0 million in Q4 2022, with the low at $914000.0 in Q4 2023.
• The 5-year median for Other Accumulated Expenses is $996000.0 (2025), against an average of $1.3 million.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses soared 100.92% in 2022, then plunged 53.25% in 2023.
• Cullinan Therapeutics' Other Accumulated Expenses stood at $973000.0 in 2021, then jumped by 100.92% to $2.0 million in 2022, then slumped by 53.25% to $914000.0 in 2023, then jumped by 57.22% to $1.4 million in 2024, then tumbled by 30.69% to $996000.0 in 2025.
• Business Quant data shows CGEM's Other Accumulated Expenses at $996000.0 in Q4 2025, $1.4 million in Q4 2024, and $914000.0 in Q4 2023.